A small Texas reactor reached criticality in under a year, aiming to produce medical isotopes that US hospitals now import
A new reactor coming online could add domestic supply of medical isotopes and reduce import dependence for US hospitals.
Source →The trace
How it reaches your house.
Starting from TENEX (JSC Techsnabexport), we walked the supply graph hop by hop to the goods you buy and the companies you own. Each step is the engine’s reasoning, scored for confidence and cited where a source backs it.
First impact
Kazatomprom →Prices riseLow-Enriched Uranium (LEU) Nuclear Fuel
A new reactor coming online increases demand for reactor fuel, and Kazatomprom is a meaningful LEU supplier (22% market share), so this could modestly support LEU pricing, though the reactor is small and the linkage is indirect.
33% confidenceHop 2
Low-Enriched Uranium (LEU) Nuclear Fuel →Stands to benefitA new reactor creates incremental demand for LEU fuel, and Urenco's sole-qualified status makes it a likely marginal beneficiary despite the reactor's small size.
63% confidenceLow-Enriched Uranium (LEU) Nuclear Fuel →Stands to benefit
Where it lands
What you buy, and what you own.
Goods you buy
No consumer goods on this path.
Companies you may own
Urenco GroupTENEX (JSC Techsnabexport)KAP.LOrano SA
Tap a company to see what it told the SEC could break it.
In the MyPRIA app, this is checked against your own holdings.